Skip to main navigation Skip to search Skip to main content

Phase II Study of Palbociclib (PD-0332991) in CCND1, 2, or 3 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1B

  • Amy S. Clark
  • , Fangxin Hong
  • , Richard S. Finn
  • , Angela M. DeMichele
  • , Edith P. Mitchell
  • , James Zwiebel
  • , Fernanda I. Arnaldez
  • , Robert J. Gray
  • , Victoria Wang
  • , Lisa M. McShane
  • , Larry V. Rubinstein
  • , David Patton
  • , P. Mickey Williams
  • , Stanley R. Hamilton
  • , Mehmet S. Copur
  • , Samer S. Kasbari
  • , Ravneet Thind
  • , Barbara A. Conley
  • , Carlos L. Arteaga
  • , Peter J. O’Dwyer
    • Lyndsay N. Harris, Alice P. Chen, Keith T. Flaherty

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II Study of Palbociclib (PD-0332991) in CCND1, 2, or 3 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1B'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science